Global Schizophrenia Treatment Market Report Sheds Light on Evolution and Innovations until 2031: Focus on Atypical Antipsychotics and High-Growth Regions
January 31, 2024 10:26 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
IntelGenx Receives CIPO Notice of Allowance for Loxapine VersaFilm™ Patent
July 05, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, July 05, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) (“IntelGenx” or the “Company”), a leading oral drug delivery company primarily focused on the...
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
February 18, 2014 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today successful results from a pilot bioequivalence study...